Combining GANs and reinforcement learning for drug discovery

(InSilico Medicine, Inc.) Insilico Medicine publishes a new research paper in Molecular Pharmaceutics journal titled 'Adversarial Threshold Neural Computer for Molecular De Novo Design.' The described Adversarial Threshold Neural Computer (ATNC) model based on the combination of Generative Adversarial Networks (GANs) with Reinforcement Learning (RL) is intended for the design of novel small organic molecules with the desired set of pharmacological properties.

from EurekAlert! - Social and Behavioral Science https://ift.tt/2IrdgMj